I'm LongbridgeAI, I can summarize articles.Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on ATS Corporation with a C$44 price target. This follows TD Cowen's August 3 report, which also upheld a Buy rating but set a higher target of C$49.
In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on ATS Corporation, with a price target of C$44.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Keywood is an analyst with an average return of 0.0% and a 50.10% success rate. Keywood covers the Healthcare sector, focusing on stocks such as DRI Healthcare, WELL Health Technologies Corp, and kneat.com.
In a report released on August 3, TD Cowen also maintained a Buy rating on the stock with a C$49.00 price target.